SVP Therapy Development
Saluda Medical
Bloomington, Minnesota, United States
Dean M Karantonis graduated with the BE(Hons) degree in computer engineering and the MBiomedE degree in biomedical engineering from UNSW, Sydney, Australia. He completed a PhD degree with the Graduate School of Biomedical Engineering at UNSW in collaboration with industry partner Ventracor, focussed on real-world control of an implantable rotary blood pump.
Dr Karantonis was a pivotal member of the NICTA Implant Systems group, which developed a world-first closed-loop neuromodulation technology. He went on to lead the engineering development of the Evoke Spinal Cord Stimulation (SCS) System for the treatment of chronic pain at Saluda Medical. From 2017, he led the product development group, during which time the Evoke System was granted its first commercial approvals and was submitted to the FDA. Shifting focus to leveraging Saluda’s core neural sensing technology, he was appointed to lead the newly formed Therapy Development team, focussed on understanding the neuroscience of chronic pain, and using this knowledge and data to create innovative product features, guiding them through feasibility clinical studies and on to product launch.
Dr Karantonis has authored numerous journal papers and conference proceedings, coauthored a book chapter on physiological measurement, is a coinventor of numerous patents, and is an IEEE member.
Emerging Technology: Saluda Medical
Thursday, January 22, 2026
2:20 PM - 2:40 PM PST
Thursday, January 22, 2026
4:10 PM - 5:00 PM PST